News
The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a ...
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
9d
Verywell Health on MSNNot an 'Easy Way Out': How GLP-1 Users Navigate the Stigma of Weight Loss DrugsDespite her active and healthy lifestyle, Sasha Barden felt stuck in her weight loss journey. She decided to try GLP-1 ...
Another challenge is brewing for restaurants. It’s not the economy, another global disease, or a weather disaster. It’s the ...
According to the clinic, these side effects should be reported to your care team as soon as possible. For Lloyd, only 3 days ...
We are just starting to learn more about the systemic impact of these medications,” Dr. Shiara Ortiz-Pujols told The Post.
17d
HealthDay on MSNGLP-1 Receptor Agonists Not Linked to Increased Risk of Psychiatric Adverse Events, DepressionGLP-1 receptor agonists are associated with improvements in restrained eating, emotional eating behavior, QOL.
1d
bpHope.com on MSNCan GLP-1s Help People With Bipolar Disorder?GLP-1s are gaining interest for their impact on weight, blood sugar, and possibly mood in bipolar disorder. Here’s what ...
21don MSN
Research on weight loss drugs like Ozempic shows varied results for mental health impacts, with some patients experiencing ...
To fully understand the role of GLP-1RAs in managing diabetes and depression, further randomized controlled trials and long-term studies are needed, Guo added. Reference: Tang H, Lu Y, Donahoo WT, et ...
There were associations for GLP-1 RA treatment vs placebo with improvements in restrained eating and emotional eating behavior and in mental health-related QOL. HealthDay News — For patients ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results